ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/08 | 2,166 | 2,166 | 2,118 | 2,124 | -46 | -2.1% | 88,000 |
2019/07/05 | 2,167 | 2,171 | 2,146 | 2,170 | -7 | -0.3% | 50,300 |
2019/07/04 | 2,188 | 2,200 | 2,170 | 2,177 | -2 | -0.1% | 42,000 |
2019/07/03 | 2,191 | 2,200 | 2,172 | 2,179 | -23 | -1% | 70,100 |
2019/07/02 | 2,220 | 2,244 | 2,194 | 2,202 | -12 | -0.5% | 75,300 |
2019/07/01 | 2,194 | 2,217 | 2,175 | 2,214 | +58 | +2.7% | 66,300 |
2019/06/28 | 2,189 | 2,198 | 2,156 | 2,156 | -41 | -1.9% | 97,700 |
2019/06/27 | 2,236 | 2,241 | 2,193 | 2,197 | -44 | -2% | 123,700 |
2019/06/26 | 2,240 | 2,248 | 2,220 | 2,241 | +3 | +0.1% | 214,400 |
2019/06/25 | 2,216 | 2,249 | 2,214 | 2,238 | +6 | +0.3% | 173,700 |
2019/06/24 | 2,226 | 2,248 | 2,219 | 2,232 | +7 | +0.3% | 82,000 |
2019/06/21 | 2,246 | 2,246 | 2,217 | 2,225 | -21 | -0.9% | 139,400 |
2019/06/20 | 2,255 | 2,275 | 2,236 | 2,246 | +1 | ±0% | 143,000 |
2019/06/19 | 2,234 | 2,248 | 2,223 | 2,245 | +53 | +2.4% | 167,000 |
2019/06/18 | 2,194 | 2,218 | 2,187 | 2,192 | +28 | +1.3% | 196,100 |
2019/06/17 | 2,174 | 2,194 | 2,161 | 2,164 | +37 | +1.7% | 200,800 |
2019/06/14 | 2,119 | 2,131 | 2,088 | 2,127 | +3 | +0.1% | 165,400 |
2019/06/13 | 2,121 | 2,134 | 2,108 | 2,124 | -7 | -0.3% | 166,400 |
2019/06/12 | 2,140 | 2,153 | 2,131 | 2,131 | -10 | -0.5% | 138,400 |
2019/06/11 | 2,129 | 2,141 | 2,118 | 2,141 | +6 | +0.3% | 93,000 |
2019/06/10 | 2,117 | 2,138 | 2,104 | 2,135 | +18 | +0.9% | 116,500 |
2019/06/07 | 2,106 | 2,119 | 2,099 | 2,117 | +16 | +0.8% | 102,100 |
2019/06/06 | 2,106 | 2,119 | 2,089 | 2,101 | -5 | -0.2% | 95,500 |
2019/06/05 | 2,090 | 2,110 | 2,080 | 2,106 | +51 | +2.5% | 124,800 |
2019/06/04 | 2,058 | 2,059 | 2,018 | 2,055 | +47 | +2.3% | 99,400 |
2019/06/03 | 1,993 | 2,012 | 1,986 | 2,008 | -20 | -1% | 118,500 |
2019/05/31 | 2,044 | 2,053 | 2,023 | 2,028 | -25 | -1.2% | 113,100 |
2019/05/30 | 2,067 | 2,076 | 2,046 | 2,053 | -31 | -1.5% | 117,600 |
2019/05/29 | 2,045 | 2,094 | 2,045 | 2,084 | +12 | +0.6% | 97,400 |
2019/05/28 | 2,085 | 2,085 | 2,042 | 2,072 | -4 | -0.2% | 152,400 |
2019/05/27 | 2,085 | 2,095 | 2,069 | 2,076 | -9 | -0.4% | 94,000 |
2019/05/24 | 2,038 | 2,086 | 2,034 | 2,085 | +26 | +1.3% | 45,300 |
2019/05/23 | 2,040 | 2,069 | 2,036 | 2,059 | +18 | +0.9% | 63,800 |
2019/05/22 | 2,015 | 2,047 | 2,007 | 2,041 | +15 | +0.7% | 77,700 |
2019/05/21 | 2,013 | 2,035 | 2,008 | 2,026 | +1 | ±0% | 62,200 |
2019/05/20 | 2,037 | 2,037 | 2,016 | 2,025 | -11 | -0.5% | 40,200 |
2019/05/17 | 2,029 | 2,036 | 2,009 | 2,036 | +29 | +1.4% | 48,300 |
2019/05/16 | 1,997 | 2,009 | 1,977 | 2,007 | +4 | +0.2% | 64,600 |
2019/05/15 | 2,015 | 2,015 | 1,976 | 2,003 | -18 | -0.9% | 55,100 |
2019/05/14 | 1,989 | 2,040 | 1,976 | 2,021 | -18 | -0.9% | 92,500 |
2019/05/13 | 1,920 | 2,068 | 1,912 | 2,039 | +159 | +8.5% | 254,300 |
2019/05/10 | 1,863 | 1,934 | 1,863 | 1,880 | +7 | +0.4% | 154,200 |
2019/05/09 | 1,905 | 1,910 | 1,872 | 1,873 | -42 | -2.2% | 94,900 |
2019/05/08 | 1,922 | 1,928 | 1,904 | 1,915 | -40 | -2% | 71,100 |
2019/05/07 | 1,946 | 1,965 | 1,932 | 1,955 | -10 | -0.5% | 88,000 |
2019/04/26 | 1,976 | 1,984 | 1,960 | 1,965 | -9 | -0.5% | 61,700 |
2019/04/25 | 1,962 | 1,977 | 1,946 | 1,974 | +11 | +0.6% | 50,700 |
2019/04/24 | 1,970 | 1,990 | 1,960 | 1,963 | +10 | +0.5% | 81,300 |
2019/04/23 | 1,939 | 1,964 | 1,935 | 1,953 | +14 | +0.7% | 51,900 |
2019/04/22 | 1,929 | 1,949 | 1,922 | 1,939 | +10 | +0.5% | 28,700 |
1501~
1550
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム